Ultrasound clues could foresee IUD insertion difficulties
NCT ID NCT06806358
First seen Jul 31, 2026 · Last updated Jul 31, 2026
Summary
This study follows 200 women choosing an intrauterine device (IUD) for contraception to see if ultrasound measurements and clinical exams can predict insertion complications. Researchers will measure uterine size, position, and blood flow before insertion. The goal is to find factors that might make IUD insertion more likely to fail or cause issues, which could help doctors personalize contraceptive counseling and care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- IUD insertion procedure
- What this could lead to
- If successful, this could help doctors identify women at higher risk of IUD insertion problems, potentially reducing complications and improving contraceptive care.
- What could go wrong
- This is an observational study, so it won't test a new treatment. The findings may not apply to all populations, and the predictors identified might not be strong enough to change clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
200 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 41 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 20 -41 years * BMI 18-25 kg/m2 * Women with any parity seeking contraception and choosing IUD as their preferred method after proper and thorough counseling * Regularly menstruating women (duration of menstruation 3-7 days and length of cycle 22- 35 days). * Not using any hormonal therapy or anticoagulation Exclusion Criteria: * Cervical abnormalities. * Pregnancy or suspicion of pregnancy * Congenital or acquired uterine anomalies which distort the uterine cavity (fibroids, endometrial polyps, cervical stenosis, bicornuate uterus, hypoplastic uterus \< 6 cm) * Acute PID or a history of PID within the past 3 months * Postpartum or post-abortion endometritis within the past 3 months * Current STI or within the past 3 months (including cervicitis) * Cervical cancer * Endometrial cancer * Malignant gestational trophoblastic disease * Undiagnosed vaginal bleeding * Hypersensitivity to any component in the IUD (copper) * Less than 6 weeks postpartum. * Neurological or psychological conditions that may affect pain sensation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Iucd complication are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kasr Alainy medical school
Cairo, Cairo Governorate, 12111, Egypt